inflammatory bowel disease (IBD)
Conditions
Interventions
A nurse-based and a patient-centered (eHealth) intervention.
Based on the first study, an intervention will be developed. This intervention will consist of a tailored communication device (eHealth) a
Sponsors
Amsterdam School of Communication Research ASCoR, University of Amsterdam
Merck Sharp & Dohme B.V., gevestigd te Waarderweg 39, 2031 BN te Haarlem
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patient is diagnosed with Crohn’s disease or Ulcerative Colitis; 2. The patient is starting with one of the following new medications Azathioprine (Imuran ®), 6-mercaptopurine (Purinethol ®), Infliximab (Remicade ®), Methotrexaat (Ledertrexate ®), 6-tg (Lanvis), Adalimumab, (Humira) and other biologicals); 3. The patient is aged 18 years or older; 4. The patients can speak and read Dutch.
Exclusion criteria
Exclusion criteria: The patient has any diagnosed cognitive limitation (according to the medical file).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Information recall; 2. Medication adherence. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Nurse-patient communication; 2. Current levels of generalized anxiety; 3. Psychological distress. | — |
Contacts
Public ContactJ.C.M. Weert, van
Department of Communication Science University of Amsterdam Kloveniersburgwal 48
Outcome results
None listed